|
|
|
|
| LEADER |
04023nam a22005535i 4500 |
| 001 |
978-3-0348-0706-7 |
| 003 |
DE-He213 |
| 005 |
20210617055901.0 |
| 007 |
cr nn 008mamaa |
| 008 |
131122s2014 sz | s |||| 0|eng d |
| 020 |
|
|
|a 9783034807067
|9 978-3-0348-0706-7
|
| 024 |
7 |
|
|a 10.1007/978-3-0348-0706-7
|2 doi
|
| 050 |
|
4 |
|a RM1-950
|
| 072 |
|
7 |
|a MMG
|2 bicssc
|
| 072 |
|
7 |
|a MED071000
|2 bisacsh
|
| 072 |
|
7 |
|a MKG
|2 thema
|
| 082 |
0 |
4 |
|a 615
|2 23
|
| 245 |
1 |
0 |
|a Drugs Targeting B-Cells in Autoimmune Diseases
|h [electronic resource] /
|c edited by Xavier Bosch, Manuel Ramos-Casals, Munther A Khamashta.
|
| 250 |
|
|
|a 1st ed. 2014.
|
| 264 |
|
1 |
|a Basel :
|b Springer Basel :
|b Imprint: Springer,
|c 2014.
|
| 300 |
|
|
|a XI, 292 p. 3 illus., 2 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Milestones in Drug Therapy,
|x 2296-6056
|
| 505 |
0 |
|
|a Historic outline of the development of drugs targeting B-cells -- Understanding B-cell biology -- Pharmacological effects and mechanisms of action of agents blocking B cells -- Systemic lupus erythematosus: direct B-cell blocking -- Systemic lupus erythematosus: indirect B-cell blocking -- B-cell targeted therapies in rheumatoid arthritis -- B-cell targeted therapies in Primary Sjögren Syndrome -- Targeting B cells in ANCA-associated vasculitis -- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies -- B-cell targeted therapies in cryoglobulinemia -- B-cell targeted therapies in autoimmune cytopenias and thrombosis -- Targeting B cells in neurological autoimmune diseases -- Targeting B cells in other systemic autoimmune diseases -- Safety of B-cell targeted therapies -- The future potential of biosimilars targeting B-cells.
|
| 520 |
|
|
|a This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are discussed with respect to the use of B-cell directed therapies in neurological autoimmune diseases and autoimmune cytopenias. Situations in which B-cell targeted therapy may be indicated are identified, thereby offering comprehensive support for therapeutic decisions on the basis of the latest published evidence. The book also offers a valuable reference tool for rheumatologists, internists, nephrologists, immunologists, and all specialists involved in the multidisciplinary care of patients with rheumatic and systemic autoimmune diseases.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
|
0 |
|a Rheumatology.
|
| 650 |
|
0 |
|a Internal medicine.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B21007
|
| 650 |
2 |
4 |
|a Immunology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/B14000
|
| 650 |
2 |
4 |
|a Rheumatology.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33170
|
| 650 |
2 |
4 |
|a Internal Medicine.
|0 https://scigraph.springernature.com/ontologies/product-market-codes/H33002
|
| 700 |
1 |
|
|a Bosch, Xavier.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Ramos-Casals, Manuel.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Khamashta, Munther A.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer Nature eBook
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783034807074
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783034807050
|
| 830 |
|
0 |
|a Milestones in Drug Therapy,
|x 2296-6056
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-0348-0706-7
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 912 |
|
|
|a ZDB-2-SXB
|
| 950 |
|
|
|a Biomedical and Life Sciences (SpringerNature-11642)
|
| 950 |
|
|
|a Biomedical and Life Sciences (R0) (SpringerNature-43708)
|
